Retrospective analysis of concomitant cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer a gynecologic oncology group study

International Journal of Gynecological Cancer

Volumn 19, Issue 7, 2009, Pages 1258-1263

  Kunos, Charles ^a   Tian, Chunqiao ^b   Waggoner, Steven ^c   Rose, Peter G ^a   Lanciano, Rachelle ^d  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d Delaware County Memorial Hospital   (United States)

Author keywords

Cervical cancer; Chemoradiation; Elderly

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GASTROINTESTINAL SYMPTOM; GROUPS BY AGE; HUMAN; INTERSTITIAL RADIATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; PRIORITY JOURNAL; RADIATION DOSE; SKIN TOXICITY; THROMBOCYTOPENIA; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; UTERINE CERVIX CARCINOMA; ADJUVANT CHEMOTHERAPY; AGE; BRACHYTHERAPY; CANCER STAGING; CARCINOMA; DISEASE COURSE; DRUG ADMINISTRATION; EVALUATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; UTERINE CERVIX TUMOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 73449126941     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181b33ace     Document Type: Article

References (20)

1. Waggoner SE. Cervical cancer. Lancet. 2003;361:2217-2225.
2. Stehman FB, Bundy BN, DiSaia PJ, et al. Carcinoma of the cervix treated with radiation therapy: a multivariate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer. 1991;67: 2776-2785.
3. Lanciano R, Calkins A, Bundy BN, et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2005;23: 8289-8295.
4. Rose P, Ali S, Watkins E, et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:2804-2810.
5. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22:872-880. (Pubitemid 41103599)
6. Stehman FB, Ali S, Keys HM, et al. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol. 2007;197:503.e1-6.
7. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group Study. J Clin Oncol. 1999;17:1339-1348.
8. Peters WI, Liu P, Barrett R, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606-1613.
9. Kunos C., Gibbons H., Simpkins F, et al., during pelvic radiation for cervical cancer patients aged ≥55 years in the SEER-Medicare population, J Oncol. 2008 , 931532,Epub August 27, 2008
10. Kunos C, Gibbons H, Simpkins F, et al. during pelvic radiation for cervical cancer patients aged ≥55 years in the SEER-Medicare population. J Oncol. 2008: 931532. Epub August 27, 2008. 10. National Cancer Institute Cancer Statistics Branch. SEER Cancer Statistics Review 1975-2002 Tables 1-10 and 1-12, 2005 (vol 2007). http://seer.cancer.gov/csr/1975-2002. Accessed April 1, 2009.
11. Eifel PJ, Moughan J, Erickson B, et al. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. Int J Rad Oncol Biol Phys. 2004;60:1144-1153.
12. Wright J, Gibb R, Geevarghese S, et al. Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. Cancer. 2005;103: 85-91.
13. Mitchell P, Waggoner S, Rotmensch J, et al. Cervical cancer in the elderly treated with radiation. Gynecol Oncol. 1998;71:291-298.
14. Monk BJ, Tian C, Rose PG, et al. Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials. Gynecol Oncol. 2007;105:427-433.
15. Neugut AI, Fleischauer AT, Sundarajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002;20:2643-2650.
16. Yancik R, Wesley MN, Ries LA, et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285:885-892.
17. Samet J, Hunt WC, Key C, et al. Choice of cancer therapy varies with age of patient. JAMA. 1986;255:3385-3390. (Pubitemid 16080858)
18. Singh GK, Miller BA, Hankey BF, et al. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage and survival, 1975Y2000. Cancer. 2004;101:1051-1057.
19. Coker AL, Du XL, Fang S, et al. Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts. Gynecol Oncol. 2006;102:278-284.
20. Patel DA, Barnholtz-Sloan JS, Patel MK, et al. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of surveillance, epidemiology, and end results data. Gynecol Oncol. 2005;97:550-558.